BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 30377066)

  • 1. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.
    Hirth J; McGrath CJ; Kuo YF; Rupp RE; Starkey JM; Berenson AB
    Vaccine; 2018 Nov; 36(50):7682-7688. PubMed ID: 30377066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional variations in human papillomavirus prevalence across time in NHANES (2003-2014).
    Hirth JM; Kuo YF; Starkey JM; Rupp RE; Laz TH; Rahman M; Berenson AB
    Vaccine; 2019 Jul; 37(30):4040-4046. PubMed ID: 31182324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey.
    McClung NM; Lewis RM; Gargano JW; Querec T; Unger ER; Markowitz LE
    J Adolesc Health; 2019 Dec; 65(6):715-722. PubMed ID: 31515134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018.
    Rosenblum HG; Lewis RM; Gargano JW; Querec TD; Unger ER; Markowitz LE
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):415-420. PubMed ID: 33764964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.
    Markowitz LE; Hariri S; Lin C; Dunne EF; Steinau M; McQuillan G; Unger ER
    J Infect Dis; 2013 Aug; 208(3):385-93. PubMed ID: 23785124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine.
    Adjei Boakye E; Tobo BB; Rojek RP; Mohammed KA; Geneus CJ; Osazuwa-Peters N
    Hum Vaccin Immunother; 2017 Nov; 13(11):2713-2722. PubMed ID: 28853980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study.
    Chow EP; Danielewski JA; Fehler G; Tabrizi SN; Law MG; Bradshaw CS; Garland SM; Chen MY; Fairley CK
    Lancet Infect Dis; 2015 Nov; 15(11):1314-23. PubMed ID: 26201300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of 9-Valent Human Papillomavirus Types by Race/Ethnicity in the Prevaccine Era, United States, 2003-2006.
    Liu G; Unger ER; Hariri S; Steinau M; Markowitz LE
    Sex Transm Dis; 2016 Oct; 43(10):633-6. PubMed ID: 27631358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018.
    Stefanos R; Lewis RM; Querec TD; Gargano JW; Unger ER; Markowitz LE
    Hum Vaccin Immunother; 2024 Dec; 20(1):2308378. PubMed ID: 38372273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women.
    Whittemore D; Ding L; Widdice LE; Brown DA; Bernstein DI; Franco EL; Kahn JA
    J Womens Health (Larchmt); 2016 Nov; 25(11):1153-1158. PubMed ID: 27754751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014.
    Oliver SE; Unger ER; Lewis R; McDaniel D; Gargano JW; Steinau M; Markowitz LE
    J Infect Dis; 2017 Sep; 216(5):594-603. PubMed ID: 28931217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.
    Osborne SL; Tabrizi SN; Brotherton JM; Cornall AM; Wark JD; Wrede CD; Jayasinghe Y; Gertig DM; Pitts MK; Garland SM;
    Vaccine; 2015 Jan; 33(1):201-8. PubMed ID: 25444787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and Ethnic Group Knowledge, Perceptions and Behaviors about Human Papillomavirus, Human Papillomavirus Vaccination, and Cervical Cancer among Adolescent Females.
    Bond SM; Cartmell KB; Lopez CM; Ford ME; Brandt HM; Gore EI; Zapka JG; Alberg AJ
    J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):429-435. PubMed ID: 26915922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of oral human papillomavirus by vaccination status among young adults (18-30years old).
    Hirth JM; Chang M; Resto VA;
    Vaccine; 2017 Jun; 35(27):3446-3451. PubMed ID: 28526331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen.
    Landis K; Bednarczyk RA; Gaydos LM
    Vaccine; 2018 Jun; 36(24):3498-3504. PubMed ID: 29752025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial/ethnic disparities in human papillomavirus vaccination initiation and completion among U.S. women in the post-Affordable Care Act era.
    Agénor M; Pérez AE; Peitzmeier SM; Borrero S
    Ethn Health; 2020 Apr; 25(3):393-407. PubMed ID: 29347831
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction in Human Papillomavirus Vaccine Type Prevalence Among Young Women Screened for Cervical Cancer in an Integrated US Healthcare Delivery System in 2007 and 2012-2013.
    Dunne EF; Naleway A; Smith N; Crane B; Weinmann S; Braxton J; Steinau M; Unger ER; Markowitz LE
    J Infect Dis; 2015 Dec; 212(12):1970-5. PubMed ID: 26123561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Oral Human Papillomavirus Infection: Impact of Sex, Race/Ethnicity, and Vaccination Status.
    Berenson AB; Hirth JM; Chang M
    Clin Infect Dis; 2022 Apr; 74(7):1230-1236. PubMed ID: 34218280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination.
    Markowitz LE; Naleway AL; Lewis RM; Crane B; Querec TD; Weinmann S; Steinau M; Unger ER
    Vaccine; 2019 Jun; 37(29):3918-3924. PubMed ID: 31160099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in Vaccine-Type Human Papillomavirus Prevalence Among Women in the United States, 2009-2012.
    Berenson AB; Laz TH; Rahman M
    J Infect Dis; 2016 Dec; 214(12):1961-1964. PubMed ID: 27821406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.